Radionetics Oncology, Inc.
Pharmaceutical company · Menlo Park, California, United States
Radionetics Oncology, Inc. is a pharmaceutical company headquartered in Menlo Park, California, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $54 million sold in a notice filed in 2023.
Radionetics Oncology at a glance
What does Radionetics Oncology do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $54.2 million sold (2023).
Frequently asked questions about Radionetics Oncology
Where is Radionetics Oncology headquartered?
Radionetics Oncology, Inc. is headquartered in Menlo Park, California, United States.
What does Radionetics Oncology do?
Radionetics Oncology, Inc. is a pharmaceutical company.
When was Radionetics Oncology founded?
The earliest incorporation on record for Radionetics Oncology, Inc. is in 2021, according to public company registers.
Similar companies
- AN2 Therapeutics, Inc.Menlo Park, California, United States
- Oruka Therapeutics, Inc.Menlo Park, California, United States
- Dermira, Inc.Menlo Park, California, United States
- Orca BioSystems IncMenlo Park, California, United States
- CohBar, Inc.Menlo Park, California, United States
- Forty Seven, Inc.Menlo Park, California, United States
- Attenua, Inc.Menlo Park, California, United States
- Corium International, Inc.Menlo Park, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences